ctDNA-guided radiotherapy for non-small cell lung cancer on TKI therapy
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether using a blood test to find cancer changes (ctDNA) can help guide radiotherapy for people with non-small cell lung cancer that has started to grow again in a few places while on TKI treatment. It aims to see if this approach can help control the cancer and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Can do most daily activities
- Has non-small cell lung cancer that has spread and is currently on a first-line TKI treatment
- Has up to 5 new or growing cancer spots, all outside the brain
- These spots can be safely treated with a precise type of radiation (SBRT)
- Willing to give a blood sample for ctDNA testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a precise type of radiation called SBRT can control lung cancer that has started to grow in only a few new spots while you are on standard treatments. It may help you delay changing to a different treatment.
This study uses a blood test called ctDNA to look for leftover lung cancer after surgery. Based on that result, the trial will help decide which treatment approach is best for you and may catch cancer returning earlier.
This trial is testing whether giving focused radiation therapy to the main lung tumor, in addition to standard treatments like targeted therapy or chemo-immunotherapy, can help people with advanced lung cancer that has spread to many places. The goal is to see if adding this radiation can improve outcomes without causing too many side effects.
This trial tests whether giving high-precision radiation to a few spots that are growing during immunotherapy (with or without chemotherapy) can help people with advanced lung cancer. It aims to see if treating these limited areas of resistance can extend the time the cancer stays under control.
This trial tests if giving radiation to the main lung tumor before starting a targeted therapy pill can help delay the cancer from growing. It is for people with advanced non-small cell lung cancer that has a specific genetic change and who have not had targeted therapy before.
This trial tests whether combining two immunotherapy drugs (which help your immune system fight cancer) with a type of precisely targeted radiation (SBRT) is safe and effective for people with early-stage non-small cell lung cancer. If you qualify, you might receive a treatment that could boost your body's ability to destroy cancer cells.
Hear when a new OligoProgressive Metastatic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.